J1300 HCPCS code: Injection, eculizumab, 10 mg
J1300 is the HCPCS Level II code for injection, eculizumab, 10 mg. CMS terminated J1300 on 2025-03-31; do not bill it for later dates of service. In 2024 Medicare paid an average of $173.80 per service for J1300 across 583,090 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. Medicare volume fell 49% from 2022 to 2024 (1,134,126 to 583,090 services). In 2024, about 638 clinicians billed Medicare for J1300 for 344 beneficiaries; Texas, Alabama, Florida accounted for 47% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2008-01-01 |
| Last action effective | 2025-04-01 |
| Terminated | 2025-03-31 |
Who bills J1300 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 638 |
| Medicare beneficiaries | 344 |
| States with claims | 10 |
| Share of services in top 3 states (Texas, Alabama, Florida) | 47% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1300, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,134,126 | 645 | $221.40 | $176.78 |
| 2023 | 700,092 | 415 | $217.54 | $173.30 |
| 2024 | 583,090 | 344 | $218.17 | $173.80 |
States with the most J1300 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 64,861 | $171.87 |
| Alabama | 60,960 | $176.64 |
| Florida | 58,080 | $176.01 |
| Tennessee | 47,730 | $176.35 |
| New York | 44,325 | $174.24 |
What changed for J1300
- 2008-01-01: J1300 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1300?
J1300 is the HCPCS Level II code for injection, eculizumab, 10 mg. Short descriptor: "Eculizumab injection".
How much does Medicare pay for J1300?
In 2024, the average Medicare payment was $173.80 per service (average allowed $218.17).
Does Medicare cover J1300?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related J13 codes
- J1301 — Injection, edaravone, 1 mg
- J1302 — Injection, sutimlimab-jome, 10 mg
- J1303 — Injection, ravulizumab-cwvz, 10 mg
- J1304 — Injection, tofersen, 1 mg
- J1305 — Injection, evinacumab-dgnb, 5mg
- J1306 — Injection, inclisiran, 1 mg
- J1307 — Injection, crovalimab-akkz, 10 mg
- J1308 — Injection, famotidine, 0.25 mg
- J1320 — Injection, amitriptyline hcl, up to 20 mg
- J1322 — Injection, elosulfase alfa, 1 mg
- J1323 — Injection, elranatamab-bcmm, 1 mg
- J1324 — Injection, enfuvirtide, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1300
- Watch J1300 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1300
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.